Literature DB >> 15380523

T cells in the pathogenesis of systemic lupus erythematosus.

Robert W Hoffman1.   

Abstract

Recent studies in patients with systemic lupus erythematosus (SLE) have demonstrated that autoantigen-reactive T cells can be isolated from peripheral blood and that such cells can support autoantibody production ex vivo, suggesting that they may have a central role in the pathogenesis of disease. In addition, recent work has identified and characterized signaling abnormalities in T cells from SLE that may be fundamental to the disease. This review will examine the role of T cells in the pathogenesis of SLE and it will consider pathogenic mechanisms by which T cells escape normal of immunological tolerance. The focus will be on recent studies characterizing autoantigen-reactive human T cells and signaling abnormalities identified in T cells from patients with SLE.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15380523     DOI: 10.1016/j.clim.2004.05.001

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  39 in total

1.  Identification and characterization of a lupus suppressor 129 locus on chromosome 3.

Authors:  Francesco Carlucci; Liliane Fossati-Jimack; Ingrid E Dumitriu; Yasin Heidari; Mark J Walport; Marta Szajna; Paramita Baruah; Oliver A Garden; H Terence Cook; Marina Botto
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

Review 2.  SLE: translating lessons from model systems to human disease.

Authors:  Ram Raj Singh
Journal:  Trends Immunol       Date:  2005-09-09       Impact factor: 16.687

Review 3.  T cells and B cells in lupus nephritis.

Authors:  Mary H Foster
Journal:  Semin Nephrol       Date:  2007-01       Impact factor: 5.299

4.  Decrease of regulatory T cells in patients with systemic lupus erythematosus.

Authors:  S Mellor-Pita; M J Citores; R Castejon; P Tutor-Ureta; M Yebra-Bango; J L Andreu; J A Vargas
Journal:  Ann Rheum Dis       Date:  2006-04       Impact factor: 19.103

5.  Induction of pathogenic anti-dsDNA antibodies is controlled on the level of B cells in a non-lupus prone mouse strain.

Authors:  Dirk Langnickel; Philipp Enghard; Claudia Klein; Reinmar Undeutsch; Berthold Hocher; R Manz; G R Burmester; Gabriela Riemekasten
Journal:  J Clin Immunol       Date:  2006-01       Impact factor: 8.317

6.  Cyclooxygenase-2 polymorphisms and risk of systemic lupus erythematosus in Koreans.

Authors:  Min-Young Her; Ahmed El-Sohemy; Marilyn C Cornelis; Tae-Hwan Kim; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2006-07-27       Impact factor: 2.631

7.  Safety and efficacy of combined cyclophosphamide and rituximab treatment in recalcitrant childhood lupus.

Authors:  Ashwaq Ale'ed; Abdullah Alsonbul; Sulaiman M Al-Mayouf
Journal:  Rheumatol Int       Date:  2013-11-12       Impact factor: 2.631

8.  Analysis of the interindividual conservation of T cell receptor alpha- and beta-chain variable regions gene in the peripheral blood of patients with systemic lupus erythematosus.

Authors:  W Luo; L Ma; Q Wen; N Wang; M-Q Zhou; X-N Wang
Journal:  Clin Exp Immunol       Date:  2008-09-22       Impact factor: 4.330

9.  Differential calcium signaling and Kv1.3 trafficking to the immunological synapse in systemic lupus erythematosus.

Authors:  Stella A Nicolaou; Lisa Neumeier; Koichi Takimoto; Susan Molleran Lee; Heather J Duncan; Shashi K Kant; Anne Barbara Mongey; Alexandra H Filipovich; Laura Conforti
Journal:  Cell Calcium       Date:  2009-12-02       Impact factor: 6.817

10.  Increased expression of ganglioside GM1 in peripheral CD4+ T cells correlates soluble form of CD30 in Systemic Lupus Erythematosus patients.

Authors:  Lingli Dong; Shaoxian Hu; Fang Chen; Xiaomei Lei; Wei Tu; Yikai Yu; Liu Yang; Wei Sun; Takuro Yamaguchi; Yasufumi Masaki; Hisanori Umehara
Journal:  J Biomed Biotechnol       Date:  2010-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.